PTX3 and hepatocellular carcinoma: Although the addition of AFP to PTX3 did not significantly increase the diagnostic ability of PTX3 alone for AFP-negative HCC, the combination of PTX3 with AFP improved diagnostic accuracy when only early-stage HCC was evaluated.